{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:18:50Z","timestamp":1760645930349},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[1999,5]]},"abstract":"<jats:p>\n            <jats:italic>Abstract<\/jats:italic>\n            \u201411\u03b2-Hydroxysteroid dehydrogenases (11\u03b2-HSD) interconvert cortisol, the physiological glucocorticoid, and its inactive metabolite cortisone in humans. The diminished dehydrogenase activity (cortisol to cortisone) has been demonstrated in patients with essential hypertension and in resistance vessels of genetically hypertensive rats. 11\u03b2-Hydroxysteroid dehydrogenase type 2 (11\u03b2-HSD2) catalyzes only 11\u03b2-dehydrogenation. However, a functional relationship between diminished vascular 11\u03b2-HSD2 activity and elevated blood pressure has been unclear. In this study we showed the expression and enzyme activity of 11\u03b2-HSD2 and 11\u03b2-HSD type 1 (which is mainly oxoreductase, converting cortisone to cortisol) in human vascular smooth muscle cells. Glucocorticoids and mineralocorticoids increase vascular tone by upregulating the receptors of pressor hormones such as angiotensin II. We found that physiological concentrations of cortisol-induced increase in angiotensin II binding were significantly enhanced by the inhibition of 11\u03b2-HSD2 activity with an antisense DNA complementary to 11\u03b2-HSD2 mRNA, and the enhancement was partially but significantly abolished by a selective aldosterone receptor antagonist. This may indicate that impaired 11\u03b2-HSD2 activity in vascular wall results in increased vascular tone by the contribution of cortisol, which acts as a mineralocorticoid. In congenital 11\u03b2-HSD deficiency and after administration of 11\u03b2-HSD inhibitors, suppression of 11\u03b2-HSD2 activity in the kidney has been believed to cause renal mineralocorticoid excess, resulting in sodium retention and hypertension. In the present study we provide evidence for a mechanism that could link impaired vascular 11\u03b2-HSD2 activity, increased vascular tone, and elevated blood pressure without invoking renal sodium retention.\n          <\/jats:p>","DOI":"10.1161\/01.hyp.33.5.1179","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:53:46Z","timestamp":1339462426000},"page":"1179-1184","update-policy":"http:\/\/dx.doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":33,"title":["11\u03b2-Hydroxysteroid Dehydrogenase in Cultured Human Vascular Cells"],"prefix":"10.1161","volume":"33","author":[{"given":"Haruhiko","family":"Hatakeyama","sequence":"first","affiliation":[{"name":"From the Third Department of Internal Medicine, Fukui Medical University (Japan)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Inaba","sequence":"additional","affiliation":[{"name":"From the Third Department of Internal Medicine, Fukui Medical University (Japan)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isamu","family":"Miyamori","sequence":"additional","affiliation":[{"name":"From the Third Department of Internal Medicine, Fukui Medical University (Japan)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","first-page":"1561","volume":"4","year":"1982","unstructured":"Kornel L, Ramsay C, Kanamarlapudi N, Travers T, Packer W. Evidence for the presence in arterial walls of intracellular-molecular mechanism for action of mineralocorticoids. Clin Exp Hypertens. 1982;4:1561\u20131582.","journal-title":"Clin Exp Hypertens"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641968009038550"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.23.1.25"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)51084-5"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.135.5.7956952"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.25.2.170"},{"key":"e_1_3_2_7_2","first-page":"639","volume":"40","year":"1996","unstructured":"Hatakeyama H, Miyamori I, Takeda Y, Yamamoto H, Mabuchi H. The expression of steroidogenic enzyme genes in human vascular cells. Biochem Mol Biol Int. 1996;40:639\u2013645.","journal-title":"Biochem Mol Biol Int"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.29.1.45"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3037703"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90742-8"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2845584"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)55351-5"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(95)03546-J"},{"key":"e_1_3_2_14_2","first-page":"821","volume":"2","year":"1987","unstructured":"Stewart PM, Valentino R, Wallace AM, Burt D, Shackleton CHL, Edwards CRW. Mineralocorticoid activity of liquorice: 11beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet. 1987;2:821\u2013823.","journal-title":"Lancet"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0895-394"},{"key":"e_1_3_2_16_2","first-page":"687","volume":"77","year":"1993","unstructured":"Nikkila H, Tannin GM, New MI, Taylor NF, Kalaitzoglou G, Monder C, White PC. Defects in the HSD11 gene encoding 11\u03b2-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. J Clin Endocrinol Metab. 1993;77:687\u2013691.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.25.1.67"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.27.2.197"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)00513-3"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.23.5.577"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(94)90030-2"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a121726"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0039-128X(94)00074-M"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1480419"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(94)90016-7"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1995.1231"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(92)90570-B"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.20.1.67"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-129-6-3305"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.132.2.8425481"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.87.1.8419017"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(90)92845-S"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1984.246.4.H608"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1139\/y85-250"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-125-2-1046"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.31.1.459"},{"key":"e_1_3_2_37_2","first-page":"207","volume":"60","year":"1997","unstructured":"Brem AS, Bina RB, Hill N, Alia C, Morris DJ. Effects of licorice derivatives on vascular smooth muscle function. Life Sci. 1997;60:207\u2013214.","journal-title":"Life Sci"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199304000-00004"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199110243251706"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1989.tb01295.x"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.6.2.236"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.33.5.1179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T17:18:51Z","timestamp":1715534331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.33.5.1179"}},"subtitle":["Possible Role in the Development of Hypertension"],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["10.1161\/01.HYP.33.5.1179"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.33.5.1179","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5]]},"assertion":[{"value":"1998-09-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-01-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}